| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman &CEO | Director
2 companies
Bentsur Ron is a Chairman &CEO at Nuvectis Pharma, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 14 buys and 0 sells.
Estimated insider holdings value: $44.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 300 | $14.73 | $4,418.40 | - | -46.2% | -55.7% | |
| Jul 21, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 335 | $14.92 | $4,997.85 | - | -39.6% | -55.3% | |
| Jul 19, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 200 | $14.33 | $2,866.00 | - | -34.2% | -55.0% | |
| Jul 14, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 260 | $15.52 | $4,035.40 | - | -36.1% | -56.0% | |
| Jul 6, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 320 | $14.88 | $4,761.60 | - | -27.5% | -59.3% | |
| Jun 26, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 750 | $16.50 | $12,375.00 | - | -16.6% | -56.8% | |
| Jun 21, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 500 | $17.88 | $8,940.00 | - | -19.7% | -61.5% | |
| Jun 8, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 350 | $17.45 | $6,107.90 | - | -19.4% | -63.8% | |
| May 31, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 330 | $17.28 | $5,702.40 | - | -17.0% | -63.4% | |
| May 24, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 200 | $17.49 | $3,498.00 | - | -14.4% | -61.3% |